Postoperative cure in Iranian patients with gastric cancer: estimating the crude conditional probability in a relative survival setting in the presence of competing risks

[1]Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol. 2006; 12:17–20.YangLIncidence and mortality of gastric cancer in ChinaWorld J Gastroenterol20061217–2010.3748/wjg.v12.i1.17407748516440411Search in Google Scholar

[2]Fock KM, Ang TL. Epidemiology of Helicobacter pylori infection and gastric cancer in Asia. J Gastroenterol Hepatol. 2010; 25:479–86.FockKMAngTLEpidemiology of Helicobacter pylori infection and gastric cancer in AsiaJ Gastroenterol Hepatol201025479–8610.1111/j.1440-1746.2009.06188.x20370726Search in Google Scholar

[3]International Agency for Research on Cancer. GLOBOCAN [Internet]. 2012 [cited 2017 Jul 05]. Available from: http://globocan.iarc.fr/International Agency for Research on CancerGLOBOCAN [Internet]2012[cited 2017 Jul 05]. Available fromhttp://globocan.iarc.fr/Search in Google Scholar

[4]Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, et al. Recent patterns in gastric cancer: a global overview. Int J Cancer. 2009; 125:666–73.BertuccioPChatenoudLLeviFPraudDFerlayJNegriEet alRecent patterns in gastric cancer: a global overviewInt J Cancer2009125666–7310.1002/ijc.2429019382179Search in Google Scholar

[5]Hussein NR. Helicobacter pylori and gastric cancer in the Middle East: A new enigma? World J Gastroenterol. 2010; 16:3226–34.HusseinNRHelicobacter pylori and gastric cancer in the Middle East: A new enigma?World J Gastroenterol2010163226–3410.3748/wjg.v16.i26.3226290071320614477Search in Google Scholar

[6]Malekzadeh R, Derakhshan MH, Malekzadeh Z. Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med. 2009; 12:576–83.MalekzadehRDerakhshanMHMalekzadehZGastric cancer in Iran: epidemiology and risk factorsArch Iran Med200912576–83Search in Google Scholar

[7]Haidari M, Nikbakht MR, Pasdar Y, Najaf F. Trend analysis of gastric cancer incidence in Iran and its six geographical areas during 2000-2005. Asian Pac J Cancer Prev. 2012; 13:3335–41.HaidariMNikbakhtMRPasdarYNajafFTrend analysis of gastric cancer incidence in Iran and its six geographical areas during 2000-2005Asian Pac J Cancer Prev2012133335–4110.7314/APJCP.2012.13.7.3335Search in Google Scholar

[8]Matsuhisa T, Aftab H. Observation of gastric mucosa in Bangladesh, the country with the lowest incidence of gastric cancer, and Japan, the country with the highest incidence. Helicobacter. 2012; 17:396–401.MatsuhisaTAftabHObservation of gastric mucosa in Bangladesh, the country with the lowest incidence of gastric cancer, and Japan, the country with the highest incidenceHelicobacter201217396–40110.1111/j.1523-5378.2012.00967.x346974022967124Search in Google Scholar

[9]Howlader N, Ries LA, Stinchcomb DG, Edwards BK. The impact of underreported Veterans Affairs data on national cancer statistics: analysis using population-based SEER registries. J Natl Cancer Inst. 2009; 101:533–6.HowladerNRiesLAStinchcombDGEdwardsBKThe impact of underreported Veterans Affairs data on national cancer statistics: analysis using population-based SEER registriesJ Natl Cancer Inst2009101533–610.1093/jnci/djn517272070819318639Search in Google Scholar

[10]Zeraati H, Amiri Z. Estimating postoperative survival of gastric cancer patients and factors affecting it in Iran: based on a TNM-7 Staging System. Acta Med Iran. 2016; 54:114–8.ZeraatiHAmiriZEstimating postoperative survival of gastric cancer patients and factors affecting it in Iran: based on a TNM-7 Staging SystemActa Med Iran201654114–8Search in Google Scholar

[11]Adham D, Abbasgholizadeh N, Abazari M. Prognostic factors for survival in patients with gastric cancer using a random survival forest. Asian Pac J Cancer Prev. 2017; 18:129–34.AdhamDAbbasgholizadehNAbazariMPrognostic factors for survival in patients with gastric cancer using a random survival forestAsian Pac J Cancer Prev201718129–34Search in Google Scholar

[12]Dikshit RP, Mathur G, Mhatre S, Yeole BB. Epidemiological review of gastric cancer in India. Indian J Med Paediatr Oncol. 2011; 32:3–11.DikshitRPMathurGMhatreSYeoleBBEpidemiological review of gastric cancer in IndiaIndian J Med Paediatr Oncol2011323–1110.4103/0971-5851.81883312498621731209Search in Google Scholar

[13]Dickman PW, Coviello E. Estimating and modeling relative survival. Stata J. 2015; 15:186–215.DickmanPWCoviello E. Estimating and modeling relative survivalStata J201515186–21510.1177/1536867X1501500112Search in Google Scholar

[14]Dickman PW, Adami HO. Interpreting trends in cancer patient survival. J Intern Med. 2006; 260:103–17.DickmanPWAdamiHOInterpreting trends in cancer patient survivalJ Intern Med2006260103–1710.1111/j.1365-2796.2006.01677.x16882274Search in Google Scholar

[15]Lambert PC, Dickman PW, Osterlund P, Andersson T, Sankila R, Glimelius B. Temporal trends in the proportion cured for cancer of the colon and rectum: a population-based study using data from the Finnish Cancer Registry. Int J Cancer. 2007; 121:2052–9.LambertPCDickmanPWOsterlundPAnderssonTSankilaRGlimeliusBTemporal trends in the proportion cured for cancer of the colon and rectum: a population-based study using data from the Finnish Cancer RegistryInt J Cancer20071212052–910.1002/ijc.22948Search in Google Scholar

[16]Lambert PC, Thompson JR, Weston CL, Dickman PW. Estimating and modeling the cure fraction in population-based cancer survival analysis. Biostatistics. 2007; 8:576–94.LambertPCThompsonJRWestonCLDickmanPWEstimating and modeling the cure fraction in population-based cancer survival analysisBiostatistics20078576–9410.1093/biostatistics/kxl030Search in Google Scholar

[17]Eloranta S, Lambert PC, Andersson TM, Bjorkholm M, Dickman PW. The application of cure models in the presence of competing risks: a tool for improved risk communication in population-based cancer patient survival. Epidemiology. 2014; 25:742–8.ElorantaSLambertPCAnderssonTMBjorkholmMDickmanPWThe application of cure models in the presence of competing risks: a tool for improved risk communication in population-based cancer patient survivalEpidemiology201425742–810.1097/EDE.0000000000000130Search in Google Scholar

[18]Andersson TM, Dickman PW, Eloranta S, Lambert PC. Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models. BMC Med Res Methodol. 2011; 11:96. doi: 10.1186/1471-2288-11-96AnderssonTMDickmanPWElorantaSLambertPCEstimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival modelsBMC Med Res Methodol2011119610.1186/1471-2288-11-96Open DOISearch in Google Scholar

[19]Cronin KA, Feuer EJ. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival. Stat Med. 2000; 19:1729–40.CroninKAFeuerEJCumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survivalStat Med2000191729–4010.1002/1097-0258(20000715)19:13<1729::AID-SIM484>3.0.CO;2-9Search in Google Scholar

[20]Lambert PC, Dickman PW, Nelson CP, Royston P. Estimating the crude probability of death due to cancer and other causes using relative survival models. Stat Med. 2010; 29:885–95.LambertPCDickmanPWNelsonCPRoystonPEstimating the crude probability of death due to cancer and other causes using relative survival modelsStat Med201029885–9510.1002/sim.3762Search in Google Scholar